Sid Choraria presented his in-depth investment thesis on Kobayashi Pharmaceutical (TSE: 4967) at Japan Investing Summit 2013.
About the instructor:
Sid Choraria, based in Hong Kong, is a value investor and Managing Partner of Marwar Capital. Previously, Sid worked at Goldman Sachs (Asia) LLC within the Technology, Media and Telecom Investment Banking Division in Hong Kong. Prior to joining Goldman Sachs in 2011, Sid worked as a buy-side analyst at Bandera Partners, a deep value-oriented, special situations hedge fund in New York performing extensive bottom-up, fundamental research and financial analysis, with focus on downside risk and asymmetric payoffs. Previously, Sid worked at Morgan Stanley and Merrill Lynch in Hong Kong and New York. Sid received his MBA from New York University Leonard N. Stern School of Business where he was a Harvey Beker Scholar with a focus on Corporate Finance. Sid completed the Value Investing course taught by Professor Greenwald at Columbia Business School’s Executive MBA program. At Stern, Sid was a member of the Value Fund within the Michael Price Investment Fund, a fund at NYU seeded by legendary value investor Michael Price.
Members, log in below to access the full session.
Not a member?
Thank you for your interest. Please note that MOI Global is closed to new members at this time. If you would like to join the waiting list, complete the following form: